Research output per year
Research output per year
Personal profile
Research interests
Dr. Fernanda Festa has focused her career in the use of genomics and proteomics approaches to study cancer cell biology, to understand the molecular mechanism for cancer progression and to identify new drug targets that could be used for the treatment of cancer patients. Currently, she is working with pediatric and adult neuronal tumors, including neuroblastoma and glioblastoma, to identify novel mechanisms through which oxidative stress and calcium entry mediated by the ion channel TRPM2 (Transient receptor potential melastatin 2) increases drug resistance, cell proliferation and tumor progression.
Education/Academic qualification
Postdoctoral Fellowship, Arizona State University
Jun 2007 → Jun 2014
Postdoctoral Fellowship, Harvard Medical School
Mar 2007 → Jun 2009
Biochemistry and Molecular Biology, PhD, Universidade de Sao Paulo, Brazil
Aug 2002 → Mar 2007
Molecular Science (Honors) and Biology/Health Sciences, BS, Universidade de Sao Paulo, Brazil
Feb 1998 → Jun 2002
Fingerprint
Dive into the research topics where Fernanda Festa is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Kinase inhibitor screening in self-assembled human protein microarrays
Festa, F. & Labaer, J., Oct 2019, In: Journal of Visualized Experiments. 2019, 152, e59886.Research output: Contribution to journal › Article › peer-review
Open Access -
Large expert-curated database for benchmarking document similarity detection in biomedical literature search
RELISH Consortium, 2019, In: Database. 2019, p. 1-67 67 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Protein microarrays
Festa, F. & LaBaer, J., Jan 1 2019, Proteomics for Biological Discovery. wiley, p. 29-61 33 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter
-
The Human Transient Receptor Potential Melastatin 2 Ion Channel Modulates ROS Through Nrf2
Bao, L., Festa, F., Freet, C. S., Lee, J. P., Hirschler-Laszkiewicz, I. M., Chen, S. J., Keefer, K. A., Wang, H. G., Patterson, A. D., Cheung, J. Y. & Miller, B. A., Dec 1 2019, In: Scientific reports. 9, 1, 14132.Research output: Contribution to journal › Article › peer-review
Open Access8 Scopus citations -
Ibrutinib inhibition of ERBB4 reduces cell growth in a WNT5A-dependent manner
Rauf, F., Festa, F., Park, J. G., Magee, M., Eaton, S., Rinaldi, C., Betanzos, C. M., Gonzalez-Malerva, L. & Labaer, J., Apr 1 2018, In: Oncogene. 37, 17, p. 2237-2250 14 p.Research output: Contribution to journal › Article › peer-review
Open Access19 Scopus citations